Sun Pharma Advanced Research Company Limited (SPARC) has announced an Extraordinary General Meeting (EGM) scheduled for Monday, February 9, 2026, at 4:00 PM IST, to be conducted via video conferencing. The EGM will address two key special businesses.

Firstly, the company proposes to issue up to 3,85,10,000 warrants, convertible into equity shares, on a preferential basis to Shanghvi Finance Private Limited, a part of the promoter group. The issue price for each warrant is ₹155.80, with a total issue size aggregating to ₹5,99,98,58,000. The warrants can be exercised within 18 months from the allotment date. A warrant subscription price of ₹38.95 per warrant is payable upfront, with the balance of ₹116.85 per warrant payable upon exercise.

Secondly, the EGM will seek approval for the adoption and implementation of the 'SPARC Employees Stock Option Scheme 2026' (ESOP Scheme 2026). Under this scheme, up to 50,00,000 stock options, corresponding to 50,00,000 equity shares, will be granted to eligible employees and directors. This represents approximately 1.54% of the company's paid-up share capital as of December 31, 2025. The scheme also extends to employees of subsidiary, holding, and associate companies.

Remote e-voting for the EGM will commence on Thursday, February 5, 2026, at 9:00 AM IST and conclude on Sunday, February 8, 2026, at 5:00 PM IST. The cut-off date for e-voting eligibility is Monday, February 2, 2026.